Brief: Metsera To Address Pfizer's Litigation In Court
03/11/2025 16:07
Nov 3 (Reuters) - Metsera Inc MTSR.O: METSERA ISSUES STATEMENT IN RESPONSE TO LITIGATION TO ADDRESS PFIZER'S LITIGATION IN COURT "PFIZER IS TRYING TO LITIGATE ITS WAY TO BUYING METSERA FOR A LOWER PRICE THAN NOVO NORDISK" Source text: ID:nPn7WsS5ja Further company coverage: MTSR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Metsera
See all newsFactbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up